AUSTIN, Texas, Feb. 22, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX), today announced for the third consecutive year it has been named one of the 25 Fastest-Growing Technology Companies in America by Forbes. Luminex technology helps clinicians and researchers discover and pinpoint the cause of diseases and infections, create new medical therapies, identify genetic diseases and protect the public from bio-threats through its xMAP® Technology.
"Luminex continues to execute its strategic initiatives and being named to the 25 Fastest-Growing Technology Companies list for a third straight year is a testament to the hard work of our employees around the world," said Patrick J. Balthrop, president and chief executive officer of Luminex Corporation. "Our continued growth is the result of our commitment to improve the health, safety and quality of life for people worldwide, by developing innovative applications for our multiplexing xMAP Technology."
More than 7,000 Luminex instruments have been shipped to laboratories worldwide, making the company's technology the most widely implemented multiplexing platform in the world. The company's unique xMAP Technology platforms perform up to 500 simultaneous tests for nucleic acids and proteins on a single sample, providing clinicians, researchers and safety experts with quick, accurate, and cost-effective results.
In 2010, Luminex launched its newest instrument, MAGPIX®, an analytical instrument that is capable of performing up to 50 tests on a single sample and providing nearly 5,000 data points in under an hour. Additionally, the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CYP2D6 Kit, which enables a personalized medicine approach to help physicians manage patients for whom they may prescribe certain drugs that are metabolized by the enzyme cytochrome P450 2D6.
Companies named to the Forbes 25 Fastest-Growing Technology Company list must have sales of $25 million and sales growth of at least 10 percent over the last 12 months. Companies also must have double-digit median three- to five-year earnings-per-share growth estimates. Companies were ranked on their five-year annualized sales growth, which had to be no less than 10 percent.
More information on Forbes' list of America's 25 Fastest-Growing Tech Companies can be found at http://www.forbes.com.
About Luminex CorporationLuminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP Technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP Technology can be obtained at www.luminexcorp.com.Luminex Investor Contact:Matthew Scalo, 512.219.8020Sr. Director Investor Relationsmscalo@luminexcorp.comLuminex Media Contact:Mimi Torrington, 512.219.8020Director of Marketing Communicationsmtorrington@luminexcorp.comAaron DeLucia, firstname.lastname@example.org
|SOURCE Luminex Corporation|
Copyright©2010 PR Newswire.
All rights reserved